YouTube12m· Dec 2017· cataloged

Longevity: TAME study funded! Metformin Trial for Anti-Aging


What this covers

This is a short solo video in which Ford Brewer, a physician focused on preventing heart attack, stroke, cancer, disability, and dementia, explains the newly funded TAME study, short for Targeting Aging with Metformin. He says a dietician named David alerted him to it. The principal investigator is Nir Barzilai. Brewer says the study was designed and written four years before it was funded, and that the funding was announced in September 2017 on USA Today and NBC Nightly News. He also notes that it came out of the National Institutes of Aging with hundreds of geriatricians contributing, rather than from one investigator's grant proposal.

The middle of the talk is a biochemistry primer. Brewer separates aging from the diseases it produces, arguing that heart disease, cancer, stroke, kidney disease, and Alzheimer's begin climbing in the 40s and 50s. In his view that pattern reflects changing cellular biochemistry rather than organs simply wearing out. He describes declining insulin receptors and falling activity of enzymes such as mTOR, and he links impaired glucose handling to arterial plaque. He contrasts human energy production, which runs through the TCA cycle and oxidative phosphorylation to yield about 30 units of ATP, with fungi, which rely on glycolysis alone. Metformin, he says, acts only on that first glycolytic step.

The talk also covers policy and safety. Brewer relays Barzilai's point that pharmaceutical money does not go toward aging because the FDA does not recognize it as a disease indication. He presents metformin as inexpensive, long used, and already a first-line recommendation from the American College of Endocrinology. The most contested passage disputes the Mayo Clinic's warning about lactic acidosis, citing Cochrane systematic reviews that found no significant risk in the general population. Drawing on his past work as an industry toxicologist, he adds that every drug carries risk and that metformin is more benign than it is usually portrayed.

Sharpest takeaway

The TAME study investigates metformin as an anti-aging drug by targeting glucose metabolism and cellular energy production, the root biochemical mechanisms underlying age-related diseases, rather than treating individual diseases in isolation.

  • Aging is the strongest risk factor for most chronic diseases (heart disease, cancer, stroke, kidney disease, Alzheimer's), not the diseases themselves causing aging
  • Metformin works by improving glucose metabolism and cellular respiration (glycolysis, TCA cycle, oxidative phosphorylation), which decline with age and drive disease development
  • Treating aging upstream prevents multiple diseases simultaneously rather than having specialists treat individual organs

The claims · ranked19 claims · weighted by value

This asset isn't compiled yet

You're seeing its claims, ranked. Compile it to build the argument threads, weight them, and check each claim against your library — the full view.

0.80

The speaker has spent time as a toxicologist in industry and can attest that even benign substances like oxygen and water can be lethal in excessive doses, so all prescription drugs have risks but metformin is far more benign than commonly portrayed.

normativehigh valueestablishednovelty 2/4durability 4/4· Ford Brewer

“I know there a lot of metformin haters out there there is no drug that I'm aware of oh actually even I've spent some time as a toxicologist in industry and that can tell you err I mean too much oxygen has killed people too much water has killed people so any prescription drug has its issues metformin is not alone but it's actually far more benign than it's being given credit for”

0.75

Glucose metabolism, cell respiration, and the ability of cells to generate energy are the fundamental processes that hundreds of geriatricians believe are causing the chronic diseases associated with aging.

causalhigh valueestablishednovelty 2/4durability 3/4· Ford Brewer

“these dozens and hundreds of jerry traditions throughout the world when they win the institute of national institute of aging says well what's causing all of this heart disease stroke cancer disa their perspective is duh it's glucose metabolism cell respiration the ability of the cell to generate energy”

0.75

Dr. Nir Barzilai's perspective is that Big Pharma pours significant money into drug development but none into development for aging as a disease indication because the FDA has not yet approved aging as a disease indication, despite aging being the number one risk factor for most chronic diseases.

causalhigh valueestablishednovelty 2/4durability 3/4· Ford Brewer

“dr. Barzilai is very excited about the idea of approving a medication for the indication of aging his point is the Big Pharma pour a lot of money into drug development but none of them are pouring money into drug development for aging because fda has yet approved aging as a disease indication but as you'll see through this slide deck aging is the number one risk factor for most of the diseases that we're looking at here”

0.74

Aging is the strongest risk factor for age-related diseases like heart disease, cancer, stroke, emphysema, pneumonia, diabetes, kidney disease, and Alzheimer's, with most of these diseases starting to increase in incidence in the 40s and 50s.

factualhigh valueestablishednovelty 1/4durability 4/4· Ford Brewer

“age itself is the strongest risk factor for age-related diseases now that's sort of like so obvious it makes you wonder what are we saying well look at these diseases heart disease cancer stroke emphysema pneumonia diabetes and look at these and the list goes on kidney disease Alzheimer's you name it so Alzheimer's for example goes it was a little bit longer but most of these others start cranking up in the 40s and 50s”

0.71

Metformin impacts only glycolysis (the initial breakdown of glucose), not the downstream TCA cycle and oxidative phosphorylation that generate the majority of ATP energy in humans.

factualhigh valueestablishednovelty 2/4durability 3/4· Ford Brewer

“this is only a portion of glycolysis that's actually the area that's impacted by metformin a fungus which makes wine-and-cheese only has glycolysis it only breaks down glucose we as humans take that broken down glucose the 3 and the 3 carbon we break a 6 carbon down glucose down to 3 carbons take that 3 carbon and burn it for other stuff but way back up in the very beginning where we're doing glycolysis just like that fungus”

0.69

As humans age, many cellular components of glucose metabolism and energy generation decline, including insulin receptors and key enzymes like AMPK, mTOR (mammalian target of rapamycin), and SIRT1, which leads to impaired glucose uptake and utilization in cells.

causalhigh valueestablishednovelty 1/4durability 3/4· Ford Brewer

“a lot of our metabolism our cell biology begins to break down as we get old the insulin receptors for example other enzymes and we've identified a lot of them ampk mTOR mammalian target of rapamycin sirt1 you know and you see these mentioned in things like NMM other medications that are being targeted for launch so the ability to bring sugar out of the blood into the cell this is the cell membrane by the way bring sugar out of the blood into the cell and then metabolize it do the first components of metabolism before we take it into glycolysis then that TCA cycle then electron transport all of those begin to age as they do”

0.69

Impaired glucose metabolism and cellular energy production lead to the development of arterial plaque, which causes heart disease, kidney disease, and dementia.

causalhigh valueestablishednovelty 1/4durability 3/4· Ford Brewer

“we start to develop plaque in our arteries we start to develop heart disease so that plaque in the arteries then leads to heart disease kidney disease dementia so again we're going and this team study is going back and say it let's take a look at the original insults in terms of aging and see if we can have an impact”

0.64

The National Institutes of Aging developed the TAME study with dozens of contributors and hundreds of geriatricians, which is unusual because most studies originate from a principal investigator and team developing an idea, writing a proposal, and submitting a grant application for review, rather than being designed by a large institutional collaboration.

factualhigh valueestablishednovelty 1/4durability 2/4· Ford Brewer

“the National Institutes of aging actually developed a study and it wasn't like most studies where the principal investigator and his or her team develop a an idea than a proposal they write a grant application they send it to NIH or one of the funding agencies they then review it that's not what happened as you can see here there are dozens of contributors and hundreds of geriatricians doctors who study aging who've been behind this study for a long time now”

0.61

There is a larger population with type 2 diabetes and insulin resistance than commonly recognized, making metformin a relevant intervention for more than just diagnosed diabetics.

factualhigh valueestablishednovelty 1/4durability 3/4· Ford Brewer

“part of the problem I think is that there's a lot more of us with type 2 diabetes and at least insulin resistance then we recognize but let's go back to the tame study age itself is the strongest risk factor for age-related diseases”

0.60

The Mayo Clinic's claim that metformin carries a significant risk of lactic acidosis is incorrect according to Cochrane systematic review studies, which show no significant risk for lactic acidosis in the general population taking metformin.

factualhigh valuecontestednovelty 2/4durability 2/4· Ford Brewer

“the worst thing that you can see is the Mayo Clinic saying lactic acidosis and the Mayo Clinic's wrong there look at the Cochrane studies it is there is not a significant risk for the general population for I like to Casa dosis with metformin maybe the other biguanide but not that one”

0.52

Nir Barzilai is excited about the concept of targeting aging and its impact on all organs simultaneously, rather than the current approach where specialists target individual diseases (heart disease, brain disease, chronic kidney disease), essentially proposing to replace disease-specific medicine with aging-focused prevention.

normativehigh valuespeaker onlynovelty 2/4durability 3/4· Ford Brewer

“he's excited about the whole idea of saying look let's look at aging and its impact on all of our organs in other words let's put the cardiologists the neurologists the nephrologist out of business because we move back one step prior to all of this and stop the cellular components of aging if we do that we're at a whole new universe in terms of managing health and disease”

0.51

Hearts, cancers, and kidneys do not have a biological shelf life of 60 years, so the exponential increase in disease incidence with age is not simply due to organs wearing out naturally but rather to changes in cellular biochemistry.

causalhigh valuespeaker onlynovelty 2/4durability 4/4· Ford Brewer

“hearts don't have a shelf life of 60 60 years cancers don't automatically disappear between 45 and 60 kidney disease for example doesn't have kidneys not have a shelf life of 60 years what's going on here”

0.34

Humans differ from fungi and molds in energy metabolism: humans use the TCA cycle (tricarboxylic acid cycle) and oxidative phosphorylation, which generate approximately 30 units of ATP energy, whereas fungi rely only on glycolysis, which produces far less ATP.

factualestablishednovelty 0/4durability 4/4· Ford Brewer

“humans have humans are different from fungi and molds they have a little bit more complicated and far more efficient and effective we breathe oxygen that's because we use a TCA cycle track our tri carb tri carbon cycle as well a tri carbon carboxylic acid cycle as well as oxidative phosphorylation the oxidative phosphorylation gives us about 30 units or ATP units of energy compared to what a fungus does which is just glycolysis”

0.34

TAME stands for Targeting Aging with Metformin, and the principal investigator is Nir Barzilai.

factualestablishednovelty 0/4durability 4/4· Ford Brewer

“tam stands for targeting aging with metformin I'm gonna go through that study today there's a lot of interesting components of this”

0.29

Metformin is inexpensive and has been used safely for years, making it an attractive candidate for a long-term anti-aging study.

factualestablishednovelty 0/4durability 3/4· Ford Brewer

“why metformin it's inexpensive bhagwan odds have been used for years so the worst thing that you can see is the Mayo Clinic saying lactic acidosis”

0.24

The TAME study (Targeting Aging with Metformin) was designed and written four years before it received funding, with an announcement in September 2017 on USA Today and NBC Nightly News.

factualestablishednovelty 0/4durability 2/4· Ford Brewer

“the tame study was designed and written up and approved four years before it's finally been funded you can see this is September 8th 2017 it's an announcement on the USA Today and the NBC Nightly News”

0.24

Metformin is already the number one drug being recommended by the American College of Endocrinology, and not something non-standard, indicating it is an accepted medical intervention.

factualestablishednovelty 0/4durability 2/4· Ford Brewer

“metformin is already the number one drug being recommended by the American College of endocrinology so again I know there plenty of metformin haters out there look I'm just reporting the the facts we do use metformin we use a lot”

0.17

The speaker (Ford Brewer) is a physician focused on preventing heart attack, stroke, cancer, disability, and dementia through medical and scientific information provision.

factualspeaker onlynovelty 0/4durability 2/4· Ford Brewer

“I'm Ford Brewer fo Rd B or e WV or with pres med prev M II D heart attack stroke cancer disability prevention - dementia prevention I do these youtubes to help provide some basic and some a little bit more detailed than basic medical scientific information around prevention and longevity”

0.10

David, a dietician who speaks on health and prevention primarily to dentists and other groups, alerted the speaker to the TAME study.

factualspeaker onlynovelty 0/4durability 0/4· Ford Brewer

“I was alerted to this by David - he's a dietician with a does a lot of speaking for health and prevention - mostly to dentists but other groups as well he alerted me to the tame study originally”